HYBRID EVENT
September 14-16, 2026 | Rome, Italy

Plant-Based Vaccines

Plant-Based Vaccines

Plant-based vaccines represent a novel approach to vaccine development, utilizing plants to produce antigens that can stimulate immune responses. This technology harnesses the natural biological systems of plants to express and accumulate specific proteins from pathogens, such as viruses or bacteria. The advantages of plant-based vaccines include scalability, cost-effectiveness, and safety, as they can be produced without the risk of contamination with human pathogens. Moreover, oral delivery of these vaccines can induce mucosal immunity, providing additional protection. Research in this area aims to develop vaccines for diseases affecting humans, livestock, and crops, contributing to public health and agricultural sustainability.

Committee Members
Speaker at Plant Science and Molecular Biology 2026 - Rajnish Khanna

Rajnish Khanna

Carnegie Science at Stanford University, and i-Cultiver, Inc., United States
Speaker at Plant Science and Molecular Biology 2026 - Jeremy Sweet

Jeremy Sweet

Sweet Environmental Consultants, United Kingdom
Speaker at Plant Science and Molecular Biology 2026 - Costantino Paciolla

Costantino Paciolla

University of Bari Aldo Moro, Italy
GPMB 2026 Speakers
Speaker at Plant Science and Molecular Biology 2026 - Teja Sri Vengala

Teja Sri Vengala

Rare Earth Genomics, United States
Speaker at Plant Science and Molecular Biology 2026 - Gulara Huseynzade

Gulara Huseynzade

Bologna University, Italy
Speaker at Plant Science and Molecular Biology 2026 - Rachel Amir

Rachel Amir

Tel Hai University, Israel
Speaker at Plant Science and Molecular Biology 2026 - Marouane Ben Massoud

Marouane Ben Massoud

University College Cork, Ireland

Submit your abstract Today

Watsapp